Search results
AbbVie's Two-Decade Humira Monopoly Ends With Amgen's 55% Discounted Knockoff
Investor's Business Daily· 1 year agoAbbVie's two-decade Humira monopoly came to an end Tuesday after Amgen launched its biosimilar...
AbbVie's two-decade Humira monopoly came to an end Tuesday after Amgen launched its biosimilar...